Novo Nordisk to Present Hemophilia Data at ISTH 2025
June 6, 2025
Key presentations include two updates from a phase 3 trial evaluating investigational treatment with Mim8 (denecimig) and five assessing treatment outcomes with concizumab in hemophilia Novo Nordisk announced that